Bristol Myers Squibb Reaches Analyst Target Price | Nasdaq

6 days ago  · In recent trading, shares of Bristol Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $59.62, changing hands for $59.67/share. When a stock reaches ...


Install CouponFollow Chrome Extension   CouponFollow Extension

$59.62
OFF

Bristol Myers Squibb Reaches Analyst Target Price | Nasdaq

3 weeks from now

6 days ago  · In recent trading, shares of Bristol Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $59.62, changing hands for $59.67/share. When a stock reaches ...

nasdaq.com

9%
OFF

What Are Wall Street Analysts' Target Price For Bristol-Myers …

3 weeks from now

2 days ago  · Bristol-Myers Squibb’s stock prices soared 5.9% after the release of its impressive Q3 results on Oct. 31. Driven by the increase in sales of its Growth Portfolio and Eliquis, …

nasdaq.com

$53.55
OFF

BMY Crosses Above Average Analyst Target - Nasdaq

3 weeks from now

Nov 1, 2024  · In recent trading, shares of Bristol Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $53.55, changing hands for $55.77/share. …

nasdaq.com

$56.60
OFF

Bristol-Myers Squibb (BMY) Stock Forecast & Price Target

3 weeks from now

3 days ago  · According to the 21 analysts' twelve-month price targets for Bristol-Myers Squibb, the average price target is $56.60. The highest price target for BMY is $73.00, while the lowest …

marketbeat.com

$59.86
OFF

What Is The Current Price Target And Forecast For Bristol Myers …

3 weeks from now

5 days ago  · Price Target. Based on short-term price targets offered by 21 analysts, the average price target for Bristol Myers Squibb comes to $59.86. The forecasts range from a low of …

zacks.com

$42.00
OFF

Brokerages Set Bristol-Myers Squibb (NYSE:BMY) Price Target At …

3 weeks from now

Jan 8, 2025  · Barclays boosted their target price on shares of Bristol-Myers Squibb from $42.00 to $43.00 and gave the stock an "underweight" rating in a research report on Monday, October …

marketbeat.com

$61.52
OFF

Bristol-Myers Squibb (NYSE:BMY) Stock, Analyst Ratings, Price …

3 weeks from now

Bristol-Myers Squibb Co has a consensus price target of $61.52 based on the ratings of 29 analysts. The high is $85 issued by Atlantic Equities on July 28, 2023.The low is $39 issued by …

benzinga.com

$61.44
OFF

Deep Dive Into Bristol-Myers Squibb Stock: Analyst ... - Nasdaq

3 weeks from now

5 days ago  · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $61.44, along with a high estimate of $73.00 and a low …

nasdaq.com

82%
OFF

Analyst Expectations For Bristol-Myers Squibb's Future

3 weeks from now

Dec 27, 2023  · A 6.82% drop is evident in the current average compared to the previous average price target of $65.22. ... Stay up to date on Bristol-Myers Squibb analyst ratings. ... Nasdaq …

businessinsider.com

9%
OFF

What Are Wall Street Analysts' Target Price For Bristol-Myers

3 weeks from now

Bristol-Myers Squibb’s stock prices soared 5.9% after the release of its impressive Q3 results on Oct. 31. Driven by the increase in sales of its Growth Portfolio and Eliquis, BMY’s total ...

msn.com

$56.60
OFF

BMY Stock Price Target | Bristol-Myers Squibb Analyst Ratings

3 weeks from now

This price target is based on 21 analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is $56.60, with a high forecast of $73.00 and a …

pricetargets.com

$48
OFF

Unveiling 11 Analyst Insights On Bristol-Myers Squibb - Nasdaq

3 weeks from now

Oct 7, 2024  · Insights from analysts' 12-month price targets are revealed, presenting an average target of $48.0, a high estimate of $59.00, and a low estimate of $41.00.

nasdaq.com

3%
OFF

What Are Wall Street Analysts' Target Price For… - Inkl

3 weeks from now

3 days ago  · Narrowing the focus, Bristol-Myers has significantly outperformed the industry-focused First Trust Nasdaq Pharmaceuticals ETF’s 2.3% gains over the past 52 weeks and …

inkl.com

9%
OFF

What Are Wall Street Analysts' Target Price For Bristol-Myers …

3 weeks from now

2 days ago  · On Jan. 8, Truist Securities analyst Robyn Karnauskas maintained a “Buy” rating while raising the price target to $65, which indicates a 9.9% premium to current price levels. …

tradingview.com

4%
OFF

Bristol-Myers Squibb: Too Valuable Not To Hold This Pharma …

3 weeks from now

2 days ago  · Bristol-Myers Squibb (NYSE:BMY) ... which shows a 4% upside potential from the avg price target. BMY - wall st price target ... Analyst’s Disclosure: ...

seekingalpha.com

$46
OFF

What Analysts Are Saying About Bristol-Myers Squibb Stock

3 weeks from now

Sep 16, 2024  · In the assessment of 12-month price targets, analysts unveil insights for Bristol-Myers Squibb, presenting an average target of $46.0, a high estimate of $53.00, and a low …

nasdaq.com

3%
OFF

3 Cheap Dividend Stocks That Pay More Than Double The S&P 500 …

3 weeks from now

5 days ago  · Many stocks don't offer particularly high yields. The stocks in the S&P 500, for instance, average a yield of just 1.3%.That's not a terribly exciting rate of return on dividends …

fool.com

FAQs about Bristol Myers Squibb Reaches Analyst Target Price | Nasdaq Coupon?

Is Bristol-Myers Squibb a good stock to buy?

Analysts like Bristol-Myers Squibb less than other "medical" companies. The consensus rating for Bristol-Myers Squibb is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BMY compares to other companies. ...

Does Bristol-Myers Squibb have a negative revenue trend?

Negative Revenue Trend: Examining Bristol-Myers Squibb's financials over 3 months reveals challenges. As of 30 September, 2023, the company experienced a decline of approximately -2.25% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. ...

What is Bristol-Myers Squibb's net margin?

Net Margin: Bristol-Myers Squibb's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 17.58% net margin, the company effectively manages costs and achieves strong profitability. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension